EUVIMEDEUVIMED entdecken
Open Access

Depression and anxiety modify cognitive concerns associated with amyloid and early clinical impairment.

Shana D Stites iD, Rosalie Schumann, Yidan Shi iD, Dawn Mechanic-Hamilton iD, David A Wolk iD, Alzheimer’s Disease Neuroimaging Initiative

Neuropsychology · 2026

DOI: 10.1037/neu0001086 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuropsychology, 2026. Verfasst von Shana D Stites und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania. Hauptthemen laut MEDLINE: Anxiety, Depression, Alzheimer Disease, Cognitive Dysfunction. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, Alzheimer's Association, National Institutes of Health; National Institute on Aging.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Cognitive concerns (CCs) are common for patients with Alzheimer's disease (AD) dementia. We explore anxiety, depression, and clinical impairment as moderators of CCs in early AD. Understanding these associations may help inform efforts to advance early identification of disease progression in AD. METHOD: Data sources, selected based on requirements for availability of biomarker data and clinical assessment data, generated a pooled sample of adults ages 65+ with known amyloid status and cognitive function ranging from unimpaired (Clinical Dementia Rating global score [CDR-GS] = 0, n = 5,498) to early impairment (CDR-GS = 0.5, n = 504). Measures of CCs, anxiety, and depression were standardized to cognitively unimpaired groups. To model the difference in effects for different levels of anxiety and depression, we used mixed-effects quantile regression for median adjusted for age, sex, race, and educational years. All reported findings are p < .05. RESULTS: Higher CCs were associated with early clinical impairment (estimated change in median [β] = 15.5). CCs were higher with higher versus lower anxiety, except in unimpaired persons with elevated amyloid. In this latter group of unimpaired persons with elevated amyloid, CCs were higher with higher versus lower depression. CONCLUSION: In combination elevated amyloid, anxiety, and depression may offer data to guide clinical interpretation of CCs in early clinical impairment. The findings advance understanding of mood effects in early AD and inform specific measurement considerations. Future longitudinal studies are needed. (PsycInfo Database Record (c) 2026 APA, all rights reserved).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnxietyDepressionAlzheimer DiseaseCognitive DysfunctionAmyloid beta-PeptidesHumansFemaleAgedMaleAged, 80 and overDisease Progression

Substanzen

Amyloid beta-Peptides

Autor:innen und Institutionen

  • Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania.
  • Division of Biostatistics, Department of Population Health, New York University Grossman School of Medicine.
  • Department of Neurology, Perelman School of Medicine, University of Pennsylvania.

ORCID-Profile: Shana D Stites, Yidan Shi, Dawn Mechanic-Hamilton, David A Wolk

Förderung

  • NIA NIH HHS
  • Alzheimer's Association
  • National Institutes of Health; National Institute on Aging
  • National Institutes of Health

Zitieren

APA

Stites, S. D., Schumann, R., Shi, Y., Mechanic-Hamilton, D., Wolk, D. A., & Alzheimer’s Disease Neuroimaging Initiative (2026). Depression and anxiety modify cognitive concerns associated with amyloid and early clinical impairment. Neuropsychology. https://doi.org/10.1037/neu0001086

Vancouver

Stites SD, Schumann R, Shi Y, Mechanic-Hamilton D, Wolk DA, Alzheimer’s Disease Neuroimaging Initiative. Depression and anxiety modify cognitive concerns associated with amyloid and early clinical impairment. Neuropsychology. 2026. doi:10.1037/neu0001086

BibTeX
@article{Stites2026,
  author = {Stites, Shana D and Schumann, Rosalie and Shi, Yidan and Mechanic-Hamilton, Dawn and Wolk, David A and Alzheimer’s Disease Neuroimaging Initiative, Alzheimer’s Disease Neuroimaging Initiative},
  title = {Depression and anxiety modify cognitive concerns associated with amyloid and early clinical impairment},
  journal = {Neuropsychology},
  year = {2026},
  doi = {10.1037/neu0001086}
}
Kostenlos starten →